Calculating energy requirements for men with HIV/AIDS in the era of highly active antiretroviral therapy

被引：0
|
作者：
M J Batterham
J Morgan-Jones
P Greenop
R Garsia
J Gold
I Caterson
机构：
[1] Smart Foods Centre,Department of Nutrition
[2] University of Wollongong,Department of Clinical Immunology
[3] The Albion Street Centre,undefined
[4] Royal Prince Alfred Hospital,undefined
[5] Royal Prince Alfred Hospital,undefined
[6] Human Nutrition Unit,undefined
[7] University of Sydney,undefined
来源：
European Journal of Clinical Nutrition | 2003年 / 57卷
关键词：
REE; HIV; body composition;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objective: 1. To determine if resting energy expenditure (REE) adjusted for body composition is elevated in HIV-positive males when compared with healthy controls in the era of highly active antiretroviral therapy. 2. To examine the accuracy of prediction equations for estimating REE in people with HIV. 3. To determine if REE adjusting for body composition is significantly different between those HIV-positive subjects reporting lipodystrophy (LD) or weight loss (≥5%) and those who are weight stable when compared to controls.
引用
收藏
页码：209 / 217
页数：8
相关论文
共 50 条
  • [31] The neuropathology of HIV infection in the era of highly active antiretroviral therapy (HAART)
    Gray, F
    Keohane, C
    BRAIN PATHOLOGY, 2003, 13 (01) : 79 - 83
  • [32] HIV and Rheumatic disorders in the era of Highly Active Antiretroviral Therapy (HAART)
    Njobvu, P. D.
    Trollip, S.
    Chipeta, J.
    Bucala, R.
    McGill, P.
    CLINICAL RHEUMATOLOGY, 2013, 32 : S131 - S131
  • [33] Palliative care for hiv disease in the era of highly active antiretroviral therapy
    Greenberg, B
    McCorkle, R
    Vlahov, D
    Selwyn, PA
    JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 2000, 77 (02): : 150 - 165
  • [34] HIV infection in the era of highly active antiretroviral therapy:: the Malaga Study
    Santos, J
    Palacios, R
    Gutierrez, M
    Grana, M
    de la Torre, J
    Salgado, F
    Nuño, E
    Márquez, M
    INTERNATIONAL JOURNAL OF STD & AIDS, 2004, 15 (09) : 594 - 596
  • [35] HIV infection and cancer in the era of highly active antiretroviral therapy (Review)
    Barbaro, Giuseppe
    Barbarini, Giorgio
    ONCOLOGY REPORTS, 2007, 17 (05) : 1121 - 1126
  • [36] Pulmonary manifestations of HIV infection in the era of highly active antiretroviral therapy
    Wolff, AJ
    O'Donnell, AE
    CHEST, 2001, 120 (06) : 1888 - 1893
  • [37] Critical issues of HIV treatment in the era of highly active antiretroviral therapy
    Battegay, M
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2001, 10 (02) : 175 - 183
  • [38] Costs of HIV medical care in the era of highly active antiretroviral therapy
    Gebo, KA
    Chaisson, RE
    Folkemer, JG
    Bartlett, JG
    Moore, RD
    AIDS, 1999, 13 (08) : 963 - 969
  • [39] Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapy
    Jabs, DA
    Holbrook, JT
    Van Natta, ML
    Clark, R
    Jacobson, MA
    Kempen, JH
    Murphy, RL
    OPHTHALMOLOGY, 2005, 112 (05) : 771 - 779
  • [40] Unemployment as a risk factor for AIDS and death for HIV-infected patients in the era of highly active antiretroviral therapy
    Delpierre, C.
    Cuzin, L.
    Lauwers-Cances, V.
    Datta, G. D.
    Berkman, L.
    Lang, T.
    SEXUALLY TRANSMITTED INFECTIONS, 2008, 84 (03) : 183 - 186
12345